Welcome to the CURE Blog, a forum for discussions of diverse and relevant topics that impact the members of our life and health science community. CURE members span the spectrum from legacy organizations and entrepreneurial companies to suppliers and educational institutions, all of whom share a commitment to the advancement of science, creating new cures and treatments and fostering the success of fledgling companies.

What brings the community to CURE? I believe CURE is unique in its ability to reach out and support the efforts of its members through centralizing access to unique and useful information, resources, and collaboration partners.  Above all, CURE exists to serve our members. We are all part of the burgeoning ecosystem of Connecticut’s life and health science community, as well as its economic climate. My hope is that CURE will become the center of a web of connections that broadly benefit our health and life sciences community, creating jobs, retaining talent, and building a diverse understory of sustainable smaller companies. The expanding CURE vision embraces all Connecticut technology entrepreneurs and their drive to create valuable companies that support our quality of life.

Our new website, the communications hub, will serve as a virtual meeting place for our community. We will use the website, social media and this blog to announce important CURE events such as BIOHaven and Bioscience ClubhouseCT, celebrate important developments and discoveries within our member companies, share news about the new CURE Innovation Commons, offer employment opportunities, and as a relevant resource for legislators and other government officials to learn more about our members and the challenges they face. The blog will explore topics of interest to our members, representing viewpoints from frequent guest bloggers with a variety of expertise. Some topics under consideration are: the FDA and rare disease approvals, companion diagnostics, medical devices, and new investments from venture capital. We welcome comments that will inform future topics on the blog.

As part of our expansive mission, CURE is committed to providing value to established and fledgling companies by providing resources and willing minds to brainstorm about problems and new technologies, thought-provoking and informative events, and opportunities to interact with potential investors. I welcome the challenge of leading CURE and achieving its goals of sustaining a healthy and vibrant membership, helping accelerate our member companies’ progress toward their goals, and assisting members in their journeys toward discovery, wherever they fall in the science/business continuum.

By Susan Froshauer
President & CEO, CURE